Ligand Pharmaceuticals Incorporated (LGND) vs MiniMed Group, Inc. Common Stock (MMED)

A side-by-side comparison of Ligand Pharmaceuticals Incorporated and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Ligand Pharmaceuticals Incorporated logo
LGND
Ligand Pharmaceuticals Incorporated
$5.94B
$296.60HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
MiniMed Group, Inc. Common Stock logo
MMED
MiniMed Group, Inc. Common Stock
$5.52B
$19.65HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — LGND vs MMED

growth of $100 · dividends reinvested · last 1y
LGND +60.3% (+60.3%/yr)MMED +9.0% (+9.0%/yr)LGND compounded faster over this window
50100150Start $100$160$109
LGND MMED

LGND vs MMED: by the numbers

  • •LGND is the larger company ($5.94B vs $5.52B market cap).
  • •LGND is profitable (67.88% net margin) while MMED runs a net loss (-10.21%).

Metrics side by side

Valuation

MetricLGNDMMED
P/E ratio31.72N/A
Forward P/E31.8729.18
P/S ratio20.461.71
P/B ratio6.141.52
EV / EBITDA44.9730.69
FCF yield2.21%N/A

Profitability

MetricLGNDMMED
Gross margin98.58%53.85%
Operating margin17.61%0.53%
Net margin67.88%-10.21%
ROE20.38%-9.09%
ROIC3.91%0.43%

Growth (annualized)

MetricLGNDMMED
Revenue CAGR (5Y)2.92%N/A
FCF CAGR (5Y)-0.49%N/A
Total return CAGR (5Y)30.72%N/A

Frequently asked

Is LGND or MMED more profitable?
LGND runs the higher net margin — LGND at 67.88% versus MMED at -10.21%.

Go deeper

Full LGND analysisFull MMED analysisInteractive comparison tool

Dig into the metrics

Ligand Pharmaceuticals P/E ratioLigand Pharmaceuticals ROEMiniMed Group, Inc. Common Stock ROELigand Pharmaceuticals operating marginMiniMed Group, Inc. Common Stock operating marginLigand Pharmaceuticals revenue growthMiniMed Group, Inc. Common Stock revenue growthLigand Pharmaceuticals free cash flowMiniMed Group, Inc. Common Stock free cash flow

Ligand Pharmaceuticals & MiniMed Group, Inc. Common Stock appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.